Source: Diabetes Care
Key Takeaway: Digital technologies are providing remote access to educational and research meetings and, of course, to loved ones and friends who may be otherwise inaccessible. Until a proven vaccine and highly effective pharmacotherapy are developed, we need widespread testing of apparently well individuals to determine who has immunity from prior infection, who is at risk, and who is unknowingly infected. As the peak of COVID-19 begins to pass and we work to obtain better testing, pharmacotherapy, and ultimately a vaccine, we will enter a longer interval in which we must continue to support the most vulnerable populations, especially older people, those with diabetes or obesity, and those who lack the resources to limit day-today exposure to infection. We hope a growing sense of community will help in this task.